Trading statement AFROCENTRIC INVESTMENT CORPORATION LIMITED Incorporated in the Republic of South Africa Registration Number: 1988/000570/06 JSE Code: ACT ISIN: ZAE 000078416 ("AfroCentric") TRADING STATEMENT In terms of paragraph 3.4(b)(i) of the JSE Limited Listings Requirements, companies are required to provide guidance to the market when they are satisfied that a reasonable degree of certainty exists that the financial results for the six months ended 30 June 2025 (the "current reporting period") to be reported on, will differ by at least 20% from previous comparable period. Given the change in AfroCentric's financial year end, AfroCentric has set out comparative information for the six months ended 30 June 2024 and the six months ended 31 December 2024 in this trading statement. Accordingly, AfroCentric shareholders are advised that: • earnings per share for the current reporting period is expected to be between 10.15 cents and 13.00 cents in comparison to o the loss per share of 14.26 cents per share for the six months ended 30 June 2024; and o the loss per share of 14.96 cents per share for the six months ended 31 December 2024; • headline earnings per share for the current reporting period is expected to be between 11.30 cents and 12.06 cents: o reflecting a decrease of between 36.5% and 40.5% in comparison to the 19.00 cents per share for the six months ended 30 June 2024; and o reflecting an increase of between 197.4% and 217.4% in comparison to the 3.80 cents per share for the six months ended 31 December 2024. The growth in the current year earnings is attributable to revenue growth and cost containment in the Services Cluster. This growth is however diluted by tough trading conditions in the Retail Cluster, associated with the loss of some of designated service provider contracts and lower margins from pharmaceutical products. The decrease in headline earnings per share in the current reporting period when compared to the six months ended 30 June 2024 is attributed to the tough trading conditions in the Retail Cluster associated with the loss of some designated service provider contracts and lower margins from pharmaceutical products and service fees. Further information will be provided in AfroCentric's interim results for the current financial period, which are expected to be published on or about 2 September 2025. The financial information on which this trading statement is based has not been audited, reviewed, or reported on by AfroCentric's external auditors. Johannesburg 1 September 2025 Sponsor Questco Corporate Advisory (Pty) Ltd Date: 01-09-2025 09:51:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.